Your browser doesn't support javascript.
loading
Strategic priorities for hematopoietic stem cell transplantation in the EMRO region.
Ahmed, Syed Osman; El Fakih, Riad; Elhaddad, Alaa; Hamidieh, Amir Ali; Altbakhi, Abdulghani; Chaudhry, Qamar-Un-Nisa; Bazarbachi, Ali; Adil, Salman; Al-Khabori, Murtadha; Ben Othman, Tarek; Gaziev, Javid; Khalaf, Mohamad; Alshammeri, Salem; Alotaibi, Sultan; Alshahrani, Mohammed; Bekadja, Mohamed Amine; Ibrahim, Ahmad; Al-Wahadneh, Adel Mohammed; Altarshi, Muna; Alsaeed, Ahmad; Madani, Abdellah; Abboud, Miguel; Abujazar, Husam; Bakr, Mohamad; Abosoudah, Ibraheem; El Cheikh, Jean; Almasari, Ahlam; Alfraih, Feras; Baldomero, Helen; Elsolh, Hassan; Niederwieser, Dietger; Chaudhri, Naeem; Aljurf, Mahmoud.
Afiliação
  • Ahmed SO; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • El Fakih R; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Elhaddad A; National Cancer Institute, Cairo University, Cairo, Egypt.
  • Hamidieh AA; Tehran University of Medical Sciences, Hematology, Oncology & SCT Research Ctr., Tehran, Iran.
  • Altbakhi A; King Hussein Cancer Center, Amman, Jordan.
  • Chaudhry QU; Armed Forces Bone Marrow Transplant Centre/National Institute of Blood and Marrow Transplant, Rawalpindi, Pakistan.
  • Bazarbachi A; Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
  • Adil S; Department of Oncology, the Aga Khan University, Karachi, Pakistan.
  • Al-Khabori M; Sultan Qaboos University, Muscat, Oman.
  • Ben Othman T; Center National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
  • Gaziev J; National Center for Cancer Care & Research Hamad Medical Corporation, Doha, Qatar.
  • Khalaf M; Maadi Armed Forces Medical Compound Hematology/Oncology Hospital, Cairo, Egypt.
  • Alshammeri S; Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
  • Alotaibi S; Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Alshahrani M; Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Bekadja MA; University Hospital Establishment 1st Nov, Oran, Algeria.
  • Ibrahim A; Makassed General Hospital and Middle East Institute of Health Beirut, Lebanon.
  • Al-Wahadneh AM; Department of Pediatrics, Queen Rani Children's Hospital, Amman, Jordan.
  • Altarshi M; The Royal Hospital, Muscat, Oman.
  • Alsaeed A; King Abdulaziz Medical City, Ministry of National Guard, Jeddah, Saudi Arabia.
  • Madani A; Hematology, Pediatric Oncology, Ibn Rochd University Hospital, University of Hassan II, Casablanca, Morocco.
  • Abboud M; Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
  • Abujazar H; King Hussein Cancer Center, Amman, Jordan.
  • Bakr M; National Center for Cancer Care & Research Hamad Medical Corporation, Doha, Qatar.
  • Abosoudah I; King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
  • El Cheikh J; Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
  • Almasari A; King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
  • Alfraih F; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Baldomero H; University Hospital Basel, Basel, Switzerland.
  • Elsolh H; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Niederwieser D; Aichi Medical University Hospital, Nagakute, Japan.
  • Chaudhri N; University Leipzig, Germany.
  • Aljurf M; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Hematol Oncol Stem Cell Ther ; 16(3): 162-169, 2023 Apr 04.
Article em En | MEDLINE | ID: mdl-34688625
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 11_ODS3_cobertura_universal / 2_ODS3 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Hematol Oncol Stem Cell Ther Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 11_ODS3_cobertura_universal / 2_ODS3 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Hematol Oncol Stem Cell Ther Ano de publicação: 2023 Tipo de documento: Article